Introduction
Echinococcus multilocularis, commonly known as the fox tapeworm, is endemic to areas of central and northern Europe, northern Asia and parts of North America. The life cycle is primarily sylvatic, involving foxes and small herbivores such as voles, but the domestic dog can also act as a definitive host. Aberrant infection of humans results in alveolar echinococcosis, a debilitating and possibly fatal disease. A thorough knowledge of the life cycle of this parasite and its control underpins its successful exclusion from Ireland and reinforces the importance of prior praziquantel treatment of imported animals.
life cycle
Although the red fox and the arctic fox are the most well-known definitive hosts, others include the coyote, racoon dog, sand fox and Tibetan fox. Other canids, including the domestic dog, can also become definitive hosts if they ingest an intermediate host harbouring the infective metacestode. Cats are capable of acting as aberrant definitive hosts with low or negligible egg excretion. The principal intermediate hosts are small herbivores or insectivores: voles, squirrels, hamsters, mice, jerboas, shrews and, occasionally, moles and desmans. Infection in the definitive host is often asymptomatic. The adult stage of Echinococcus multilocularis is a cestode similar in appearance to Echinococcus granulosus. The cestode is 1.2mm to 4.5mm long, usually with five segments (there is a range of two to six) terminating in a sac-like 'uterus' (Figure 1) . Adults are resident deep into the crypts of Lieberkuhn of the intestinal mucosa where they cause flattening, but not disruption, of the epithelium. As there are no gross intestinal lesions, there are few or no ill effects on definitive hosts, even in the face of a heavy burden. The prepatent period is unclear but eggs are thought to be excreted by definitive hosts from day 35. 
Epidemiology and control in endemic countries
Echinococcus multilocularis is endemic to areas of France, Spain, Portugal, Greece, Germany, Austria, Switzerland, Belgium, the Czech Republic, Denmark, Liechtenstein, Luxembourg, Poland and the Slovak Republic. This range then extends east as far as Japan, Canada and the northern United States and is proposed to include parts of north Africa. The principal reservoir of infection is the native fox population, although in some areas self-perpetuating reservoirs exist in domestic dogs. Young foxes and dogs tend to have the heaviest burdens, but older animals can also be infected regardless of prior exposure.
Infection of domestic pets with Echinococcus multilocularis has been documented throughout Europe. For example, prevalence of infestation in the domestic dog and cat populations in France and Germany is estimated, from necropsy studies, to be 0.4% to 5.6%. Necropsy studies, however, will tend to overestimate prevalence in a population. Newer faecal coproantigen tests on randomly selected Swiss dogs and cats give a prevalence of 0.3% in dogs (rising to 7% in urban populations) and of 0.4% in cats (rising to 3% in urban populations). Many of these areas were previously perceived to be free from the parasite. These trends of increasing prevalence may be due to increased diagnostic accuracy or, more likely, to the spread of the parasite's range, associated with increasing urban fox population or travel of infected dogs. Irrespective of cause, this increased parasite density constitutes an increased risk to domestic pets and to the human population. Control of Echinococcus multilocularis in domestic pets living in countries where the disease is endemic involves a combination of routine anthelminthic use, public area hygiene, control of the stray dog population and, perhaps most importantly, public education. In addition, there have been efforts to control infection in the wild fox population in Germany with aircraft-dropped baits spiked with praziquantel, which have been more successful than fox culling programmes.
diagnosis and treatment
Briefly, diagnosis in intermediate and definitive hosts uses a number of techniques to achieve cestode identification. Unfortunately, routine coprological microscopic examination does not allow the differentiation of Echinococcus and Taenia spp eggs thus serology, faecal antigen ELISA or PCR are required. In living patients, ultrasound examination of abdominal organs or the characteristic cysts may be beneficial in achieving a diagnosis. Because domestic dogs and cats with intestinal Echinococcus multilocularis represent a potential risk to humans, infected animals Confirmed infected cases should receive two doses on consecutive days and, four or five days afterwards, the results should be assessed by coproantigen ELISA. Owners of infected dogs should be advised to contact their doctor for serological testing within several weeks, and for this to be repeated in six and 12 months.
Human alveolar echinococcosis
Human infection is sporadic and possibly fatal. In Europe, human alveolar echinococcosis occurs at a prevalence ranging from 0.03 (Austria) to 1.4 (Doubs, France) per 100,000 members of the population. The majority of cases are thought to be due to environmental or food contamination with infected fox or dog faeces and poor hygiene precautions. Eggs can survive for up to eight months in winter conditions and three months in summer. Alveolar echinococcosis follows ingestion of eggs that have been shed in the faeces of a definitive host. The initial phase, characterised by development of small well-encapsulated hepatic cysts, is asymptomatic, but local infiltration and secondary cyst development at distant sites occur progressively with resultant clinical signs. The incubation period prior to clinical symptoms is prolonged, perhaps five to 15 years and clinical symptoms only occur when large parts of the liver are already infiltrated (Figure 2) . Patients with infiltrative liver disease present with cholestatic jaundice, epigastric pain, fatigue, weight loss and hepatomegaly. Treatment is rarely curative and involves partial or radical surgical resection of lesions with long-term or life-long treatment with a benzimidazole, specifically albendazole. Some cases require liver transplantation. Long-term treatment is well tolerated but is parasitistatic not parasiticidal. 
Risk factors for the travelling pet

conclusions
Whilst infection in the definitive host is of little clinical significance, the potential ramifications of introduction of Echinococcus multilocularis into the Irish dog and fox populations are immense. The disease is zoonotic, often incurable and potentially fatal. Strict adherence to the routine worming of travelled dogs with praziquantel, at appropriate doses, 24 to 48 hours prior to entry into the country will minimise the likelihood of introduction of this potentially devastating disease.
